against the objections of her naggy and stubborn but well-meaning father (Takeda Tetsuya). As part of remaking herself, she changes from spectacles to contact lenses, even though she has problems ...

The journey of Takeda’s gout med Uloric—which turned rocky in recent years—has come to an end in the U.S. This week, the medicine, first approved in 2009, was listed as discontinued on the ...

Global biopharmaceutical company Takeda has launched an innovation capability centre (ICC) in Bengaluru, India, joining existing facilities in Slovakia and Mexico. The Bengaluru ICC will focus on ...

Bone-chilling temperatures couldn’t keep the crowds away from Takeda’s Kendall Square campus on Tuesday to celebrate a milestone for the Japanese drugmaker’s new R&D tower. More than 250 ...

Today, Takeda Canada Inc. ("Takeda") announced that, for the third consecutive year, it has received Top Employer® certification for 2025. Takeda is one of just 17 companies that received global ...

Aaaa Aaaaa A 113.73 +23.02% ...

Takeda has bolstered its neuroscience pipeline by licensing drug candidates from California biotech AcuraStem targeting PIKfyve, which is gathering attention as a drug target in amyotrophic ...

Evox Therapeutics is the second UK biotech to sign a big deal with a pharma giant this week, snaring an $882 million partnership with Takeda for up to five rare disease programmes. The alliance ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...